Epilepsy syndrome, infantile-onset symptomatic

Search Trials
Oral Supplementation of Gangliosides to Treat a Rare Metabolic Disorder
Status:
Unknown status
Last Changed:
Feb 7, 2019
First Changed:
Sep 9, 2014
Disease(s):
GM3 Synthase Deficiency
Intervention(s):
Supplementation of dairy-derived concentrated gangliosides.

Connect. Empower. Inspire.